Humacyte HUMA
NASDAQ HUMA
$0.65 -0.03 (-4.36%)
As of: Aug 21, 2026 · 3:26 PM EDT

Humacyte (HUMA) FCF Margin Growth (1y) (2021 - 2026)

Humacyte (HUMA) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.93 Bn 131.07 Bn 2.84 Bn -89.00
2 Regeneron Pharmaceuticals 85.91 Bn 77.92 Bn 3.93 Bn -1,183.00
3 Argenx Se 64.98 Bn 59.80 Bn 1.37 Bn -
4 Moderna 58.86 Bn 53.72 Bn 52.00 Mn 26,102.00
5 BeOne Medicines 42.03 Bn 36.93 Bn 1.53 Bn 869.00
6 Alnylam Pharmaceuticals 31.54 Bn 28.23 Bn 992.69 Mn 769.00
7 BioNTech SE 27.88 Bn 9.49 Bn 668.28 Mn 4,109.00
8 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 19,111.00
9 Royalty Pharma 27.35 Bn 26.51 Bn - 811.00
10 Humacyte 153.55 Mn 153.55 Mn -825,000.00 339,049.00

Historic Data

Download Data
DateValue
Jun 30, 2026 339,049.00
Mar 31, 2026 53,127.00
Sep 30, 2021 -1.26 Mn